Close Menu

NEW YORK – Co-Diagnostics said last week that it has been notified by Nasdaq that it failed to meet a listing requirement and may face delisting action.

In a document filed with the US Securities and Exchange Commission, the Salt Lake City-based diagnostics firm said that it received a letter on July 2 from Nasdaq informing it that its stock had closed below the minimum $1 per share requirement for 30 consecutive days. Co-Diagnostics has 180 calendar days, or until Dec. 30, to regain compliance by having its stock close at $1 or more per share for 10 consecutive days.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.